Midnolin is a novel regulator of parkin expression and is associated with Parkinson’s Disease
Abstract Midnolin (MIDN) was first discovered in embryonic stem cells, but its physiological and pathological roles are, to date, poorly understood. In the present study, we therefore examined the role of MIDN in detail. We found that in PC12 cells, a model of neuronal cells, MIDN localized primaril...
Enregistré dans:
Auteurs principaux: | Yutaro Obara, Toru Imai, Hidenori Sato, Yuji Takeda, Takeo Kato, Kuniaki Ishii |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b0a473ce608c4da7bb4b61ac2a2f43c5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson’s disease-like pathology
par: Changhe Wang, et autres
Publié: (2018) -
Cognitive alterations in juvenile Parkinson´s disease caused by the C212Y mutation in the Parkin gene.
par: Sonia Moreno, et autres
Publié: (2010) -
Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model
par: Sangwoo Ham, et autres
Publié: (2017) -
Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.
par: Thi A Tran, et autres
Publié: (2011) -
Deconstructing the molecular genetics behind the PINK1/Parkin axis in Parkinson’s disease using Drosophila melanogaster as a model organism
par: Suchita Ganesan, et autres
Publié: (2021)